Let's end restrictions on science: ASMR medallist
09 June, 2005 by Susan WilliamsonThe message from this year's Australian Society for Medical Research medallist, Julian Savulescu, was controversial but clear: we should use science to enhance humans.
Bio21 Institute opens today
08 June, 2005 by Ruth BeranAustralia's newest research institute, the AUD$100 million Bio21 Institute, based at the University of Melbourne, officially opened its doors today.
Australian, Japanese synchrotrons to partner
07 June, 2005 by Ruth BeranJapan's SPring-8, the world's largest synchrotron, has signed a new partnership with the Australian Synchrotron to share expertise and develop new technology.
Research Australia calls on govt to ramp up funding
06 June, 2005 by Ruth BeranAustralia must ramp up its investment in health and medical research to ensure its future prosperity, said Research Australia CEO Dr Christine Bennett and Australian Graduate School of Management professor Michael Vitale in a joint paper published this week in the Medical Journal of Australia.
We're open for business: CSIRO exec
06 June, 2005 by Ruth BeranThe new executive director of CSIRO's business development team, Nigel Poole, is on the campaign trail, seeking to convince the business world that the organisation is open for business.
Board changes at Bone
03 June, 2005 by Staff WritersFormer AustCancer CEO Paul Hopper has joined the board of Perth-based Bone Medical (ASX:BNE), among other changes at the company, including the resignation of Michael Perrott from the board.
XRT signs electron microscope deal with Gatan
02 June, 2005 by Ruth BeranUnlisted imaging company XRT, an investee of BioTech Capital (ASX:BTC), has entered a deal with Californian-based electron microscope accessory and software manufacturer Gatan to develop and distribute an x-ray microscope product for use with electron microscopes.
New members named to biotech advisory council
01 June, 2005 by Ruth BeranFour new members have been appointed to the Australian Biotechnology Advisory Council (ABAC) -- the independent board of industry experts advising the government on biotech issues.
Aust biotech posts three-year performance low: PwC
31 May, 2005 by Ruth BeranA new report on ASX-listed life sciences companies by PricewaterhouseCoopers shows that the sector has posted its worst quarterly performance in three years.
M&A's great -- but beware of the pitfalls
27 May, 2005 by Renate KrelleWith many biotechnology companies struggling to find investor support, the idea of banding together against the harsh elements -- merging or acquiring a like company -- is gaining currency. But there are many snares for the unwary, warns mergers and acquisitions specialist Nathan Drona.
Academy elects 16 new members
24 May, 2005 by Graeme O'NeillInternationally renowned molecular geneticist Dr Robin Holliday is among 16 Australian scientists elected this month to the Australian Academy of Science.
Liability clauses to be removed from CRC contract
23 May, 2005 by Ruth BeranThe federal government is to remove a controversial liability clause from Commonwealth contracts with new Cooperative Research Centres (CRCs), education minister Brendan Nelson told delegates at last week's 2005 CRC Association Conference in Melbourne.
In brief: Benitec, Probiomics, Progen, Avastra
23 May, 2005 by Renate KrelleQueensland Investment Corporation has ceased to be a substantial shareholder in Benitec (ASX:BLT), but millionaire Richard Pratt's Thorney Group has upped its holding in the company to 11.54 per cent.
What Alan Finkel did next
23 May, 2005 by Ruth BeranRuth Beran discovers how one of Australia's great bioentrepreneurs has moved from inspiring shareholders to inspiring a nation.
How to build your own Axon Instruments
23 May, 2005 by Alan FinkelAustralian Biotechnology News journalist Ruth Beran asked Axon Instruments founder Alan Finkel if he had any advice for Australian companies with an eye on the world stage. Here is his reply.
